Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses

A K M Mahbub Hasan1, Takashi Ijiri, Ken-Ichi Sato

  • 1Laboratory of Cell Signaling and Development, Department of Molecular Biosciences, Faculty of Life Sciences, Kyoto Sangyo University, Kyoto 603-8555, Japan ; Laboratory of Gene Biology, Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka 1000, Bangladesh.

Insights

Protein-tyrosine kinases (PTKs) are crucial for cell functions and cancer. This study examines how Src and other PTKs help cancer cells evade apoptosis under stressful conditions like hypoxia.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein-tyrosine phosphorylation, catalyzed by protein-tyrosine kinases (PTKs), regulates critical cellular processes.
  • The discovery of Src family kinases (SFKs) provided early insights into PTK function in cancer.
  • PTKs are implicated in various aspects of cancer biology and progression.

Purpose of the Study:

  • To investigate the role of Src and other PTKs in enabling cancer cells to evade apoptosis.
  • To understand how PTKs contribute to cancer cell survival under specific stress conditions.
  • To elucidate the mechanisms linking PTK activity to cancer cell-specific behaviors.

Main Methods:

  • Review of existing literature on PTKs, Src family kinases, and cancer cell apoptosis.
  • Analysis of studies detailing PTK involvement in cellular stress responses.
  • Focus on cancer cell-specific behaviors such as resistance to apoptosis.

Main Results:

  • Src and other PTKs play significant roles in promoting cancer cell survival.
  • PTKs facilitate evasion of apoptosis under conditions including hypoxia, anoikis, hypoglycemia, and serum deprivation.
  • These kinases are key regulators of cancer cell adaptation to adverse microenvironments.

Conclusions:

  • Src and other PTKs are critical mediators of cancer cell survival by inhibiting apoptosis.
  • Targeting PTK activity may represent a therapeutic strategy to overcome cancer cell resistance to cell death.
  • Understanding PTK functions in stress-induced apoptosis evasion is vital for cancer treatment development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...